TGFB1 and idiopathic pulmonary fibrosis: Resolvin D1 is one lipid mediator that is derived from eicosapentaenoic acid and docosahexaenoic acid attenuates lung inflammation and interstitial fibrosis as well as inhibits TGF-β-induced EMT suggesting it as a potential therapeutic agent against IPF.